ASHINGTON — Note to would-be Food and Drug Administration commissioners: Stop tweeting!

Two weeks ago the prospects for Silicon Valley’s Balaji Srinivasan faded after his highly critical tweets about the FDA came to public attention. Now, Dr. Joseph Gulfo, whose name surfaced Monday, might have an even trickier problem: His retweets were about President Trump.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.